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Abstract 
Rapidly increasing diabetes mellitus is becoming a serious threat to mankind health in all parts of the world. The control of 
treatment depends upon the availability medicines without any side effects. Traditional anti-diabetic plants, which can counter 
the high cost and poor availability of the current medicines. So an attempt was made to study the beneficial effects of M. 
champaca leaves extracts on pancreas morphology of diabetic rat model. M. champaca leaf extracts (Ethanolic, Chloroform 
and Petroleum Ether) were administered at dose levels of 200 mg/kg body weight orally. A positive control and normal group 
received distilled water orally. Blood samples were collected from retro-orbital plexus of each rat and analyzed by GOD-POD 
test. After 21 days treatment among different extracts, the maximum reduction of serum glucose level showed significantly 
(p<0.001) treated with ethanolic extract 200mg/kg b.w. compared to diabetic control group. The serum lipids level was 
reversed towards normal treated with all extracts when compared to diabetic control group. Histological study of the pancreas 
also assesses the islets of diabetic control group were damaged, shrunken while islets of herbal extracts group reverse the 
effect of alloxan induction which clearly showed the regeneration of beta cells and their size. Ethanolic extract at dose of 
200mg/kg b.w. brings about significant beneficial effects in various physiological/histological parameters altered diabetic 
manifestations.  
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Introduction 
Diabetes mellitus is a complex and a multifarious 
group of disorders that disturbs the metabolism of 
carbohydrates, fats and proteins. It results from 
shortage or lack of insulin secretion or reduced 
sensitivity of the tissue insulin (1). As the numbers of 
people with diabetes multiply worldwide, the disease 
takes an ever increasing proportion of national and 
international health care budgets. It is projected to 
become one of the world main disablers and killers 
within the next 25 years (2). Unfortunately, after the 
introduction of   bi-guanides and sulfonylureas about 
50 years back no major success has been obtained in 
this direction of finding a proper drug for diabetes. 
These drugs have side effects and thus searching for a 
new class of compounds is essential to overcome 
these problems (3) but management of diabetes 
without any side effects is still a challenge to the 
medical community. So prior to discovery of insulin and 
other hypoglycemic synthetic drugs, herbal medicine 
has been long used for the treatment of diabetic 
patients and they are currently accepted as an 
alternative therapy for diabetic treatment and control 
(4). Traditional antidiabetic plants might provide new 
oral hypoglycemic compounds, which can counter the 
high cost and poor availability of the current medicines 
present day drugs for many rural population in 
developing countries. India is well known for its herbal 
wealth. Medicinal plants like Trigonella foenum 
graecum, Allium sativum, Gymnema slyvestre and 
Syzigium cumini have been studied (5) for treatment of 
diabetes mellitus. However, detailed studies on the 
efficacy, mechanism of action and safety of plant 
extracts are needed. 
Michelia champaca (Magnoliaceae) having 
common name: Golden or yellow champaca, Champa, 
champaka (6). The tree is native from Asia-Tropical 
(Bangladesh, Arunachal pradesh, Assam, Bihar) and 
Indo China (Myanmar, Thialand, Vietnam, Sumatra, 
Malaysia) (7). Traditionally, it is being used in fever, 
colic, leprosy, post partum protection  (8) and in eye 
disorders (9). It has been reported to possess 
antipyretic, anti-inflammatory  (10)  insecticidal (11), 
antimicrobial  (8) and leishmanicidal activities (12). 
Juice of the leaves of Michelia champaca is given with 
honey in cases of colic. The flower oil is useful in 
cephalalgia, opthalmia and gout. The flowers and fruits 
are considered stimulant, antispasmodic, tonic, 
stomachic, bitter and cool remedies and are used in 
dyspepsia, nausea and fever. The bark is used as a 
stimulant, expectorant, astringent and febrifugal 
properties (13). The flowers mixed with sesamum oil 
forms an external application in vertigo and also 
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applied to foetid discharges from the nostrils. They are 
useful as a diuretic in renal diseases and in gonorrhoea. 
The dried root and roots bark, mixed with curdled milk, 
is useful as an application to absecesses, clearing 
away or maturing the inflammation. In the form of an 
infusion it is valuable emmenagogue. It is also 
considered purgative. The flowers and fruits in 
combination with other drugs are recommended as an 
anti-dote to snake and scorpion venoms. (14). The 
methanol extracts of leaves, seeds, stem and root 
barks, stem and root heart-woods of Michelia 
champaca and the obtained fractions (petrol, 
dichloromethane, ethyl acetate and butanol) exhibited 
a broad spectrum of antibacterial activity. Fractionation 
drastically enhanced the level of activity particularly in 
all fractions of the stem bark and dichloromethane 
fraction of the root bark. Some fractions of the leaves 
stem and root bark demonstrated antifungal activity 
against some of the tested moulds. Liriodenine was the 
active constituent of the root bark, with a broader and, 
in some cases, better level of activity as compared to 
the standard (8).   
On the basis of these facts, our present 
investigation was undertaken to study the 
histomorphological changes and anti-diabetic effect of 
Michelia champaca leaves extracts on the pancreas in 
alloxan induced diabetic model. 
Material and methods 
Experimental animals 
Sprague Dawley rats of either sex, weighing 
around 150-250gm were purchased from Local Market. 
Male animals were housed separately in groups 6 per 
cage (Polycarbonate cage size: 29x22x14 cm) under 
laboratory conditions with alternating light and dark 
cycle of 12 h each. The animals had free access to 
food and water. The animals were acclimatized for at 
least five days before behavioural experiments which 
were carried out between 09:00 to 17:00 h. The 
experimental protocol (MMCP/IEC/10/02) was 
approved by Institutional Animals Ethics Committee 
(IAEC) and animals care was taken as per guidelines 
of Committee for the Purpose of Control and 
Supervision of Experiments on Animals (CPCSEA), 
Govt. of India. 
Drugs and chemicals  
All the solvents and chemicals used in this study 
were of pharmaceutical grade. Diagnostic kits were 
purchased from Ecoline, Merck Ltd., (Mumbai, India), 
Glbenclamide HCL was gifted by USV Ltd. Baddi, 
Himachal Pradesh., India. Alloxan monohydrate was 
purchased from Sigma Aldrich.  
Collection of plant materials 
Leaves of M. champaca as shown in Fig 1 were 
collected in the month of November 2009 from 
Botanical garden, Punjab University, Chandigarh, India. 
The specimen plant (NISCAIR/RHMD/consult/-2009-
10/1337/139) was identified with the help of literature 
and authenticated by Dr. H. B. Singh, Scientist F & 
Head, Raw Materials Herbarium and Museum, 
N.I.S.C.A.I.R, New Delhi, India. The fresh plant 
material were cleaned with distilled water to dry at 35º-
40ºC for 10 days and, pulverized in electric grinder and 
the powder was passed through sieve No.60 and used 
for further extraction. 
 
Fig. 1: Plant of Michelia Champaca 
 
 
 
 
 
 
 
 
 
 
 
Preparation of extracts 
Dried and powdered plant material (1000 g) was 
successively Soxhlet extracted with petroleum ether 
(60-80o), chloroform, ethanol for 72 h each according 
to their polarity. The obtained extracts were evaporated 
in vacuum to give residues and their percentage yields 
were determined (15)  
 
Induction of diabetes  
Preparation of Normal Saline Solution: To make 
Normal Saline Solution (0.9%), weigh the 0.9 g of NaCl 
on physical balance and dissolved in sufficient distilled 
water to make volume up to 100 ml. 
Preparation of Alloxan Monohydrate Solution: 
Weigh 2g of alloxan monohydrate was dissolved in 100 
ml of 0.9% sodium chloride to obtain 2% alloxan 
monohydrate solution. 
Preparation of 0.2% CMC: Weigh 200mg CMC 
were dissolved in 100ml of Normal Saline solution and 
heat at 50ºC with continuously shaking with stirrer. 
 
Experimental design  
The animals were divided into six groups of each 
containing six. 
Group 1: Normal operated + treated with Saline 
Group 2: Diabetic induced (Positive control) 
Group 3: Diabetic induced + treated with 
Glbenclamide (5mg / kg, b.w/day /oral) 
Group 4: Diabetic induced + treated with Pet. 
Ether extract of M.champaca 200 mg / kg, b.w/day/oral. 
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Group5: Diabetic induced + treated with 
Chloroform extract of M.champaca 200 mg / kg, 
b.w/day/oral. 
Group6: Diabetic induced + treated with Ethanolic 
extract of M.champaca 200 mg / kg, b.w/day/oral.  
Group-1 was treated as Normal rats and group-2 
to group-6 were made diabetic by single intraperitoneal 
injection of alloxan monohydrate 120mg/kg. Following 
injection, animals were carefully observed for the first 
24 hrs for any evidence of allergic reaction, behavioral 
changes and convulsions. No untoward reaction was 
observed in any animal. Blood was collected. The 
diabetic state was confirmed after 3 days of alloxan 
administration and rats with serum blood glucose levels 
of >140mg/dl were included in the study. Blood 
samples were drawn from retroorbital plexus at weekly 
interval till the end of study. Fasting blood glucose 
levels, HDL, LDL, Triglycerides and serum insulin 
levels were measured before & at the 7th, 14th & 21st 
day. 
 
Histopathology of pancrease 
The whole pancreas from each animal was 
removed after sacrificing the animal and washed on ice 
cold saline immediately. A portion of pancreatic tissue 
was fixed in 10% neutral formalin fixative solution for 
histological studies. After fixation tissues were 
embedded in paraffin, solid sections were cut at 5μm 
and the sections were stained with haematoxylin and 
eosin (16). 
 
Statistically analysis 
The data were expressed as mean ± SEM. The 
statistical significance between means was analyzed 
using one-way analysis of variance (ANOVA) followed 
by Tukey’s multiple comparison test. A p<0.005 was 
considered as statistically significant.      
 
Results 
Administration of alloxan (120 mg/kg, i.p.) led to 
elevation of fasting blood glucose levels, which was 
maintained over a period of 3 weeks and daily 
treatment of various extract of Michelia champaca led 
to a dose-dependent fall in blood sugar levels. The 
plant extract were fed with diabetes induced rats. The 
serum glucose level of all the extracts of M. champaca 
treated groups were significantly (P<0.001) reduced 
when compared to the diabetic control group but 
ethanolic extract having the highest depletion power 
from 219 ± 1.44 to 151.71±1.93 at 21st day (Table 1). 
Table 2 showed the data for serum Cholesterol, 
LDL, HDL and Triglycerides respectively. The serum 
cholesterol level of chloroform extract treated group 
(188.11 ± 29.4 mg/dl) and ethanolic extract treated 
group (169.25± 29.4mg/dl) showed statistically highly 
significant (P<0.001) compared to diabetic control group 
(274 ± 21.9 mg/dl) at 21st day similar results in case of 
Triglycerides at 21st day, the ethanolic extract 
demonstrated the better result and found significant (P< 
0.001) compared to diabetic control group but in Pet. 
Ether treated group, it was found non-significant in 
serum cholesterol level and triglyceride levels. In LDL 
parameter, only Ethanolic extract treated group showed 
statistically significant (P< 0.001) compare to diabetic 
control group rather than other extracts which were non 
significant. In case of HDL level all the extracts showed 
non signficant reduction of HDL levels at 21st day.
 
Table: 1 Effect of Michelia champaca extracts on Serum Glucose level in diabetic rats 
  
 
Values are Mean ± SEM 
Data was analyzed by one-way ANOVA followed by Tukey’s t test 
Statistically significant value: 
* P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, ns- non significant  
Group (n=6) Serum Glucose level(mg/dl) 
0 day 
 
7th day 14th day 21st day 
Normal 89.37±11.19 
 
80.74±14.71 85.17±21.43(ns) 84.21±10.46*** 
Diabetic control 
 
248.12±28.04 
 
263.31±9.32(ns) 258.17±18.71(ns) 268.45±6.450 
Glbenclamide 
(10mg/kg) 
 
223.10±2.80 
 
162.18±51.09* 133.21±23.74*** 98.45±21.30*** 
Pet. Ether 
(200mg/kg) 
 
279.16±23.17 
 
251.21±42.18(ns) 218.01±19.03** 164.93±1.03*** 
Chloroform 
(200mg/kg) 
 
253.13±2.91 
 
231.17±31.91(ns) 203.12±17.44** 173.41±15.32*** 
Ethanol 
(200mg/kg) 
 
219±1.44 
 
202.10±1.32*** 184.93±6.19*** 151.71±1.93*** 
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Table: 2   Effect of extract of Michelia champaca on Serum Lipid Profile in diabetic rats 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are Mean ± SEM 
Data was analyzed by one-way ANOVA followed by Tukey’s t test 
Statistically significant value: 
 
In histopathology of pancreas  
The islets of langerhans of normal group (Fig. 2a) 
were unevenly scattered in the pancreatic tissue and 
they were often quite abundantly distributed and were 
of varying sizes in the sane lobule of pancreas. The 
acinar cells which stained strongly were arranged in 
lobules with prominent nuclei. The islets cells were 
seen embedded within the acinar cells and surrounded 
by fine capsule. Pancreatic islets of diabetic control 
group 2 rats revealed significant architectural the 
acinar cells around the islets through seem to be in 
normal proportion does not look classical. (Fig. 2b) 
shows the islets were damaged, shrunken in size and 
infiltration of lymphocytes was observed. The islets 
cells of glbenclamide treated group (Fig. 2c) seen to be 
normal in position but few in numbers comparable to 
normal group. The size of cell is to be back in normal 
position after 21 days treatment of Glbenclamide. The 
islet cells were compactly arranged, with negligible 
intercellular space. In pet ether treated Group (Fig. 2d), 
the islets cells were seen in few numbers. The size of 
the cell is shrunken with architectural disarray and 
hydrolyses compared to diabetic control group. The 
islets cells (Fig. 2e) of chloroform extract treated group 
were shown to be in normal position restoration of beta 
cell size is to be back again after 21 days treatment 
compared to pet ether group. The islets of ethanolic 
extract treated group (Fig. 2f) were present with a large 
proportion of islets cells, though with a smaller volume 
compared to normal group. Ethanolic extract showed 
better restoration of beta cell in comparison of Pet 
ether and chloroform extract of Michelia Champaca. 
 
Fig. 2 (a) Group A (Normal group) Received 0.5 ml of Normal 
saline 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2 (b) Group B (Diabetic Control) Received 0.5 ml of Normal 
saline   
 
 
 
 
 
 
Group (n=6) 
 
Serum Lipid Profile (mg/dl) 
 
Serum 
Cholesterol 
 
Triglycerides 
 
LDL 
 
HDL 
 
Normal 
 
153±9.4*** 
 
 
82.91±2.1*** 
 
90.1713±3.9*** 
 
39.02±17.3ns 
 
Diabetic control 
 
274±21.9 
 
193.15±10.4 
 
203.34±51.2 
 
31.02±12.09 
 
Glbenclamide 
(10mg/kg) 
 
44.23±33.4*** 
 
99.82±11.3*** 
 
82.19±21.6*** 
 
48.99±10.14ns 
 
Pet. Ether 
(200mg/kg) 
 
259.12±18.1ns 
 
180.55±1.2ns 
 
193.14±5.6ns 
 
34.86±3.04ns 
 
Chloroform 
(200mg/kg) 
 
188.11±29.4*** 
 
141.06±44.2* 
 
167.54±7.91ns 
 
42.13±19.1ns 
 
Ethanol 
(200mg/kg) 
 
169.25±22.9*** 
 
123.77±52.9** 
 
139.11±14.7*** 
 
52.23±1.03ns 
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Fig. 2 (c) Group C (Glbenclamide treated Group) Received 
10mg/kg/day, p.o   
 
 
 
 
 
 
 
 
 
 
Fig. 2(d) Group D (Pet ether treated group) Received 
200mg/kg/day,p.o 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2(e) Group E (Chloroform treated Group) Received 
200mg/kg/day, p.o    
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2(f) Group F (Ethanol treated group) Received 
200mg/kg/day, p.o 
 
 
 
 
 
 
 
 
 
 
Discussion 
The researchers conducted over last several 
decades has shown plant and plant based therapies 
have a potential to control and treat diabetes (17-19) 
and its complications (20). Only 15% of Pharmaceutical 
drugs are consumed in developing countries and 
relatively more affluent people take more a large 
proportion of herbal drugs because, they are safe, 
more dependable and do permanent cure of their 
diseases .They are better than Allopathic drugs, which 
have a lot of adverse side effects,(21). For testing 
antidiabetic potential of plants, alloxan and STZ 
induced hyperglycemia in rats is considered to be a 
good preliminary screening model (18) and is widely 
used. Alloxan is well known for its selective pancreatic 
islet cell toxicity and has been extensively used 
induced diabetes mellitus in animals. 
The unique capacity of alloxan to selectively 
destroy the pancreatic beta cells was first described by 
Dunn et al. Alloxan induces “chemical diabetes” in a 
wide variety of animal species by damaging the insulin 
secreting pancreatic β-cell, resulting in a decrease in 
endogenous insulin release (22). The majority of islet 
cells is formed by B cells which are responsible for 
producing insulin. Depletion of B cells will therefore 
result in insulin deficiency which will lead to a disorder 
in carbohydrate, protein and fat metabolism with 
resultant hyperglycaemia. In this study alloxan which 
selectively destroy B cells of the islets was used to 
induce type 1 diabetes (23). The plant Michelia 
champaca (Sampige), in this study is widely used in 
both Ayurveda and Homeopathic medicine. Michelia 
champaca (Magnoliaceae) is commonly used by many 
traditional healers in most of the herbal preparations for 
diabetes and kidney diseases. 
Therefore the present study was to demonstrated 
the efficacy of Michelia champaca in the reduction of 
blood glucose concentration as well as to determine 
the recovery of beta cells of pancreas. This work 
evaluated biochemical parameters such as serum 
triglycerides, cholesterol, LDL, HDL in experimental 
diabetes caused by alloxan in rats. Our study indicated 
that Michelia champaca extracts have good anti-
diabetic activity. Among different extracts, ethanolic 
extract was found to be declined very fast (P<0.001) on 
7th, 14th and 21st day which showed statistically highly 
significant. Three weeks of daily treatment of various 
extract of Michelia champaca led to a dose-dependent 
fall in blood sugar levels. 
They can also improve the conditions of Diabetes 
Mellitus as indicated by parameters like triglycerides, 
Serum LDL and HDL. The ethanolic extract and 
chloroform extract showed some improvement in 
serum triglycerides levels on 21st day when compare to 
diabetic control group which were found to be 
statistically significant (p<0.001). The damage of 
pancreas in alloxan-treated diabetic control rats Fig 2b 
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and regeneration of β-cells by glibenclamide Fig. 2c 
was observed. The comparable regeneration was also 
shown by Chloroform and Ethanolic extracts of M. 
champaca Fig. 2e & 2f resp. The possible mechanism 
by which M. champaca brings about its hypoglycaemic 
action may be due to flavonoids present in this plant 
which stimulates the receptor on the cytoplasm side of 
the membrane, a protein phosphokinase of the 
tyrosine-specific type. It phosphorylates itself with the 
aid of ATP, undergoes a conformational change, and 
activates via a G-proteins, which liberates several 
second messenger further activates protein P-kinases 
which open a Ca2+ influx gives insulin like effect (24). 
Another possible mechanism may be due to alkaloids 
causes inhibition of mitochondrial function that 
increases the AMP/ATP ratio, which could explain the 
activation pathway in the treatment of diabetes (25). 
The third most important probable mechanism of action 
may be by potentiating the insulin effects of plasma by 
increasing either the pancreatic secretion of insulin 
from the existing beta cells or by its release from the 
bound form. Though the exact mechanism is unknown 
but we are assuming that various active constituents of 
this plant help to improve in treatment of diabetes.  
 
Conclusion 
In Alloxan induce diabetic model, the treatment of 
M.Champaca extracts showed a significant decrease in 
the serum glucose level, which could be due to 
improvement in insulin secretion by recovery of 
pancreatic β-cell. Phenolic compounds, flavonoids 
have been found to be beneficial in controlling diabetes 
and many other diseases as evident from earlier 
studies. It is concluded from the data that M. champaca 
possess significant antidiabetic activity and it may 
prove to be effective for the treatment of Type 1 
Diabetes. 
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